Viscosupplementation Market Analysis

ID: MRFR/HC/5788-CR

200 Pages

Rahul Gotadki

April 2025

Viscosupplementation Market Research Report By Application (Osteoarthritis, Rheumatoid Arthritis, Sports Injuries, Joint Surgery, Other Orthopedic Conditions), By Product Type (Hyaluronic Acid, Protein-Based Products, Steroid Injections, Platelet-Rich Plasma, Other Viscosupplements), By Route of Administration (Intra-Articular Injection, Intravenous Injection, Intrasynovial Injection), By End U...

Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Viscosupplementation Market Industry Landscape

The market dynamics of viscosupplementation, a medical intervention related to the injection of hyaluronic acid into joints, are stimulated by means of a combination of things inclusive of the growing old populace, the growing occurrence of osteoarthritis, and advancements in clinical technology. The worldwide growth within the growing old population is a significant driving force for the viscosupplementation market. As individuals age, the chance of osteoarthritis, a not-unusual degenerative joint disease, rises. Viscosupplementation offers a non-surgical choice to control osteoarthritis symptoms, in particular in weight-bearing joints just like the knee. Viscosupplementation serves as an alternative to surgical interventions, consisting of joint replacement surgery, for coping with osteoarthritis signs and symptoms. The non-surgical nature of viscosupplementation appeals to sufferers seeking a remedy for joint pain and stiffness without undergoing important surgical techniques. While viscosupplementation has historically been related to knee osteoarthritis, its packages are expanding to different joints. Shoulder, hip, and ankle viscosupplementation are gaining attention, broadening the market's scope and addressing the desires of patients with osteoarthritis in various joints. Growing affected person preference for conservative and non-surgical treatments contributes to the demand for viscosupplementation. Patients are more and more inclined towards interventions that offer symptomatic alleviation without the ability dangers and recuperation time associated with surgical procedures. The reimbursement landscape plays a critical role in market dynamics. Changes in repayment guidelines and extended coverage for viscosupplementation methods can impact the accessibility of these treatments for patients, influencing market growth and adoption. The market is witnessing a trend closer to combining viscosupplementation with different therapeutic modalities. Combining hyaluronic acid injections with bodily remedy, analgesics, or anti-inflammatory medicinal drugs is visible as a complete method of managing osteoarthritis, contributing to a more holistic affected person care model. The availability of clinical proof supporting the efficacy of viscosupplementation and the incorporation of pointers for its use impact market dynamics. As greater studies validate the benefits of this intervention, healthcare experts are likely to combine viscosupplementation into their remedy algorithms. Challenges in the viscosupplementation market consist of variable affected person responses to remedy, the want for repeated injections, and the capacity for damaging reactions. Addressing those demanding situations via ongoing research, customized remedy plans, and upgrades in product formulations is vital for the market boom.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected growth of the Viscosupplementation market?

The Viscosupplementation market is the expected increase in total market value of 7.31 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Viscosupplementation market?

Viscosupplementation market size was valued at approximately 2.6 billion USD in 2024. This figure will reach 7.31 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Viscosupplementation market?

Viscosupplementation market is expected to grow at a CAGR of 9.84% between 2025 and 2035.

How much will the Viscosupplementation market be worth by 2035?

Viscosupplementation market is expected to be worth of 7.31 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Viscosupplementation market perform over the next 10 years?

Over the next 10 years the Viscosupplementation market is expected to shift from usd billion 2.6 to 7.31 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

Which application has the largest market share in the Global Viscosupplementation Market?

Osteoarthritis holds the largest share with a market value of 2.25 USD Billion in 2024.

What is the market size for the Rheumatoid Arthritis segment by 2035?

The Rheumatoid Arthritis segment is projected to reach 1.5 USD Billion by 2035.

Which region holds the highest market value in the Global Viscosupplementation Market in 2024?

North America holds the highest market value at 2.0 USD Billion in 2024.

Who are the major players in the Global Viscosupplementation Market?

Key players include Orthogen AG, Zimmer Biomet, Galderma, and Baxter International among others.

What is the expected market growth for Sports Injuries segment by 2035?

The Sports Injuries segment is projected to reach 1.5 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the Viscosupplementation Market was valued at 2.60 USD Billion in 2024 and is projected to grow to 7.31 USD Billion by 2035, with a CAGR of 9.84% from 2025 to 2035. The market is driven by the increasing prevalence of osteoarthritis, technological advancements in product formulations, and a rising demand for non-surgical treatment options. The aging population and a shift towards minimally invasive procedures further enhance market growth.

Key Market Trends & Highlights

Key trends shaping the Viscosupplementation Market include technological innovations and changing patient preferences.

The Osteoarthritis segment is expected to grow from 2.25 USD Billion in 2024 to 3.8 USD Billion by 2035. Hyaluronic Acid products dominate the market due to their effectiveness in treating joint pain. Over 50% of patients prefer viscosupplementation treatments over traditional surgeries, reflecting a shift towards non-invasive options. North America is projected to lead the market with a valuation of 2.0 USD Billion in 2024, growing to 3.25 USD Billion by 2035.

Viscosupplementation Market

CAGR

9.84%

Market Size & Forecast

2024 Market Size	USD 2.60 Billion
2035 Market Size	USD 7.31 Billion
CAGR (2025-2035)	9.84%
Largest Regional Market Share in 2024	North America.

Major Players

Key players include Orthogen AG, Zimmer Biomet, Galderma, Medytox, Fidia Farmaceutici, and Baxter International.

Market Trends

Numerous significant trends are influencing the trajectory of the Global Viscosupplementation Market. The global aging population is a substantial market driver, as senior individuals frequently experience joint-related issues, resulting in a heightened demand for viscosupplementation treatments. Furthermore, patients are increasingly inclined to opt for minimally invasive procedures, which is why they are increasingly choosing viscosupplementation over more invasive surgical alternatives. This trend is consistent with the broader healthcare initiative to prioritize patient comfort and expedite recovery periods.

Opportunity areas for investigation include the expansion of viscosupplementation products into emerging markets, where there is an increasing awareness of joint health and an improvement in healthcare infrastructure.

These regions offer a substantial potential customer base that is anxious to explore advanced treatment options. Furthermore, the demand for innovative products that improve the efficacy of viscosupplementation therapies is on the rise as patients become more informed about their health decisions. This could result in the development of new formulations and applications. The integration of technology into treatment methods has also been a notable trend in recent years. The development of combination therapies, which incorporate viscosupplementation in conjunction with other modalities, is acquiring momentum.

This trend represents a transition to personalized medicine and a recognition that individuals may benefit from therapeutic approaches that are specifically tailored to them.

In general, these trends underscore a dynamic market environment that is highly responsive to technological advancements and consumer requirements, suggesting a promising future for the Global Viscosupplementation Market.

Viscosupplementation Market Market Drivers

Market Growth Projections

The Global Viscosupplementation Market Industry is projected to experience substantial growth over the next decade. With a market value of 4.79 USD Billion in 2024, it is expected to reach 8 USD Billion by 2035, reflecting a compound annual growth rate of 4.77% from 2025 to 2035. This growth trajectory underscores the increasing demand for effective joint pain management solutions and the expanding applications of viscosupplementation in various therapeutic areas. The market dynamics are influenced by factors such as technological advancements, rising healthcare expenditures, and an aging population, all contributing to a robust outlook for viscosupplementation.

Increase in Sports Injuries

The rise in sports-related injuries is another significant driver for the Global Viscosupplementation Market Industry. As participation in sports and physical activities increases, so does the incidence of joint injuries, particularly among younger populations. Viscosupplementation offers a promising solution for athletes seeking to recover quickly and effectively from joint injuries. The demand for such treatments is likely to escalate as more athletes and active individuals turn to viscosupplementation as a means of maintaining joint health and performance. This trend further supports the anticipated growth of the market, aligning with the overall increase in health consciousness.

Growing Awareness and Acceptance

There is a notable increase in awareness and acceptance of viscosupplementation therapies among both healthcare professionals and patients. Educational initiatives and marketing efforts are enhancing understanding of the benefits of viscosupplementation in managing joint pain. This shift in perception is crucial for the Global Viscosupplementation Market Industry, as it encourages more patients to seek these treatments. As a result, the market is expected to witness a compound annual growth rate of 4.77% from 2025 to 2035. This growth is indicative of a broader trend towards non-surgical interventions in orthopedic care.

Regulatory Support and Approvals

Regulatory bodies are increasingly recognizing the benefits of viscosupplementation, leading to a more favorable environment for the Global Viscosupplementation Market Industry. Approvals of new viscosupplementation products are becoming more streamlined, which encourages manufacturers to innovate and expand their product lines. This regulatory support not only enhances market accessibility but also instills confidence among healthcare providers and patients. As a result, the market is poised for growth, with projections indicating a rise to 8 USD Billion by 2035. This supportive regulatory landscape is essential for fostering advancements in treatment options.

Advancements in Medical Technology

Technological innovations in the field of viscosupplementation are propelling the Global Viscosupplementation Market Industry forward. New formulations and delivery methods are being developed to enhance the efficacy and safety of treatments. For example, the introduction of cross-linked hyaluronic acid has shown promise in extending the duration of relief for patients. These advancements not only improve patient outcomes but also increase the acceptance of viscosupplementation as a viable treatment option. As the market evolves, it is projected to grow to 8 USD Billion by 2035, indicating a robust trajectory fueled by ongoing research and development.

Rising Prevalence of Osteoarthritis

The increasing incidence of osteoarthritis globally drives the Global Viscosupplementation Market Industry. As populations age, the number of individuals suffering from joint-related disorders rises significantly. For instance, it is estimated that by 2024, the market will reach 4.79 USD Billion, reflecting the growing demand for effective treatment options. Viscosupplementation, which involves the injection of hyaluronic acid into the joints, offers a minimally invasive alternative to surgery. This trend is particularly evident in regions with aging populations, such as Europe and North America, where healthcare systems are adapting to manage the rising burden of osteoarthritis.

Market Segment Insights

Viscosupplementation Market Application Insights

The Global Viscosupplementation Market is experiencing notable growth within the Application segment, which encompasses various conditions such as Osteoarthritis, Rheumatoid Arthritis, Sports Injuries, Joint Surgery, and Other Orthopedic Conditions. In 2024, the market is expected to be valued at 4.79 USD Billion, with the Osteoarthritis segment leading significantly with a valuation of 2.25 USD Billion, illustrating its majority holding in the market. By 2035, this important segment is projected to grow to 3.8 USD Billion as the prevalence of Osteoarthritis rises globally, driven by an aging population and increasing obesity rates.

Following closely, the Rheumatoid Arthritis segment is anticipated to have a value of 0.9 USD Billion in 2024, growing to 1.5 USD Billion in 2035, reflecting the heightened awareness regarding early diagnosis and treatment options. Additionally, Sports Injuries within the Global Viscosupplementation Market are expected to possess a valuation of 0.9 USD Billion in 2024, with a future valuation of 1.5 USD Billion in 2035, highlighting the rising participation in sports activities and corresponding injuries as an essential factor driving this growth.

The Joint Surgery segment, valued at 0.6 USD Billion in 2024, is projected to reach 1.0 USD Billion by 2035, showcasing its significance as surgical approaches improve and patient outcomes advance. Lastly, Other Orthopedic Conditions are anticipated to have a valuation of 0.14 USD Billion in 2024, expected to increase slightly to 0.2 USD Billion in 2035. This segment represents various less common orthopedic conditions utilizing viscosupplementation, showing potential for growth as awareness and treatment options expand.

Viscosupplementation Market Product Type Insights

The Global Viscosupplementation Market is witnessing notable advancements in its various product types, which contribute significantly to its overall valuation projected to reach 4.79 USD Billion by 2024. Among these product types, Hyaluronic Acid stands out as a major player due to its natural occurrence in the body and effectiveness in alleviating osteoarthritis symptoms, making it a preferred choice for both patients and healthcare providers. Protein-based products have also gained traction as they offer targeted solutions, often appealing to patients with specific needs.In addition,

Steroid Injections provide rapid relief for inflammation and pain, making them a vital option in treatment protocols. Platelet-rich plasma, being a newer entrant, is noteworthy for its ability to harness the body's healing properties, which aligns with the growing trend toward regenerative medicine. Other Viscosupplements introduce diversity in treatment options, catering to varying patient preferences and conditions. As the Global Viscosupplementation Market continues to expand, the demand for these product types is driven by increasing awareness of joint health and a rising aging population, creating numerous opportunities along with the potential challenges of regulatory scrutiny and competition.

Viscosupplementation Market Route of Administration Insights

The Global Viscosupplementation Market is witnessing significant growth, with the Route Administration segment playing a crucial role in its expansion. In 2024, the market is expected to be valued at 4.79 USD Billion, reflecting the increasing adoption of various administration methods. Among these, intra-articular injection is a prominent route known for its direct delivery to the joint space, thus providing immediate relief to patients suffering from osteoarthritis.

Furthermore, intravenous injection is also recognized for its systemic effect, although it holds a smaller share within this category.Intrasynovial injection, utilized for delivering viscosupplements into the synovial cavity, plays an important role in treating joint disorders effectively.

The Global Viscosupplementation Market data indicates a trend towards minimally invasive procedures, which patients prefer due to shorter recovery times. The increase in geriatric populations and rising incidences of joint-related ailments drive market growth, while challenges such as reimbursement issues and varying regulatory standards create obstacles. However, the continuous focus on Research and Development to innovate safer and more efficient viscosupplementation products presents substantial opportunities for market improvement.

Viscosupplementation Market

The Global Viscosupplementation Market exhibits significant growth across various End-use segments, underscoring its relevance in addressing joint health issues. By 2024, this market is valued at 4.79 USD Billion, with an expected focus on areas such as Hospitals, Clinics, Ambulatory Surgical Centers, and Rehabilitation Centers. Hospitals play a pivotal role, as they often provide comprehensive care for patients with osteoarthritis and related conditions, thus dominating the market share. Clinics and Ambulatory Surgical Centers have gained traction due to their ability to offer specialized treatments and procedures efficiently.

Rehabilitation Centers complement this by supporting patient recovery post-procedure. The rise in obesity, the aging population, and the prevalence of joint disorders contribute to the increasing demand for viscosupplementation, creating significant opportunities for growth in these sectors. Additionally, advancements in technology and patient awareness about treatment options enhance the overall market dynamics. The Global Viscosupplementation Market statistics reflect ongoing investment in healthcare infrastructures globally, focusing on improving patient outcomes and quality of life.

Get more detailed insights about Viscosupplementation Market Research Report-Forecast to 2035

Regional Insights

The Global Viscosupplementation Market exhibits notable segmentation across various regions, with North America leading the way. Valued at 2.0 USD Billion in 2024, it is projected to grow to 3.25 USD Billion by 2035, highlighting its majority holding in the market. Europe follows closely, with a valuation of 1.5 USD Billion in 2024, reaching 2.4 USD Billion in 2035, driven by increasing awareness and adoption of arthritic care solutions.

The Asia-Pacific region, valued at 0.95 USD Billion in 2024 and expected to expand to 1.6 USD Billion by 2035, showcases significant growth potential attributed to rising healthcare infrastructure.Meanwhile, South America, the Middle East, and Africa display smaller market sizes, with values of 0.2 USD Billion and 0.14 USD Billion in 2024, respectively.

However, these regions are characterized by unique challenges, including limited access to advanced treatment options. The overall Global Viscosupplementation Market revenue growth is fueled by increasing geriatric populations and the rise of chronic joint disorders, positioning it as an emerging area of opportunity across all regional markets.

Viscosupplementation Market Region

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

The competitive insights of the Global Viscosupplementation Market reveal a landscape characterized by a diverse array of players, varying strategies, and differing geographical strengths. This market, focused on the use of hyaluronic acid injections for joint pain relief, particularly in osteoarthritis patients, is bustling with innovation as companies strive to develop advanced formulations and delivery systems. Key competitive factors include product efficacy, pricing strategies, marketing approaches, and post-sales support, all of which play crucial roles in defining market share and consumer loyalty.

The landscape is also shaped by regulatory challenges and the ongoing need for clinical validations to enhance treatment credibility.

The interplay of these factors creates a dynamic environment in which companies seek to differentiate themselves, highlighting the evolving nature of the Global Viscosupplementation Market.Orthogen AG has carved out a significant presence in the Global Viscosupplementation Market through its strong focus on innovative product development and strategic partnerships. The company is recognized for its high-quality viscous solutions that cater to the evolving needs of patients suffering from joint issues. Its research and development capabilities enable Orthogen AG to introduce novel formulations that not only provide pain relief but also promote joint health.

Additionally, Orthogen AG’s commitment to quality assurance and compliance with international standards establishes its reputation among healthcare providers, ultimately driving its competitive edge in the market. The company's robust distribution network ensures widespread accessibility of its products across various regions, further solidifying its positioning within the global landscape.Zimmer Biomet plays a pivotal role in the Global Viscosupplementation Market, known for its strong portfolio of orthopedic products that encompasses various treatment modalities, including advanced viscosupplement products specifically designed for joint therapy.

This company has established a significant market presence through extensive research and innovation in the development of its product line, which includes some of the leading hyaluronic acid-based injections for osteoarthritis management. Zimmer Biomet has successfully pursued various mergers and acquisitions, bolstering its capabilities and expanding its reach into new markets, further accentuating its strength in delivering reliable solutions. With a focus on educational initiatives and partnerships with healthcare professionals, Zimmer Biomet enhances awareness of its products, positioning itself as a trusted leader in the viscosupplementation space.

Their commitment to continuous improvement and customer-centric strategies further fortifies their presence in the Global Viscosupplementation Market.

Key Companies in the Viscosupplementation Market market include

Industry Developments

Q2 2024: Anika Therapeutics Announces FDA Clearance of Integrity Implant for Knee Osteoarthritis Anika Therapeutics received FDA 510(k) clearance for its Integrity Implant, a hyaluronic acid-based device for the treatment of knee osteoarthritis, expanding its viscosupplementation product portfolio.
Q1 2024: Zimmer Biomet Launches Next-Generation Gel-One Hyaluronate in the U.S. Zimmer Biomet announced the commercial launch of its next-generation Gel-One Hyaluronate, a single-injection viscosupplement for knee osteoarthritis, in the United States.
Q2 2024: Sanofi Receives CE Mark for New Hyaluronic Acid Viscosupplement Sanofi announced it has received CE Mark approval for its new hyaluronic acid viscosupplement, enabling commercialization in the European Union for the treatment of osteoarthritis pain.
Q3 2024: Chugai Pharmaceutical Launches Suvenyl Next in Japan Chugai Pharmaceutical launched Suvenyl Next, an advanced hyaluronic acid viscosupplement, in Japan for the treatment of knee osteoarthritis.
Q2 2024: Lifecore Biomedical Expands Manufacturing Facility for Hyaluronic Acid Products Lifecore Biomedical announced the opening of a new manufacturing facility dedicated to the production of pharmaceutical-grade hyaluronic acid, supporting increased demand for viscosupplementation products.
Q1 2024: Smith & Nephew Announces Strategic Partnership with Hospital Group for Viscosupplementation Distribution Smith & Nephew entered into a strategic partnership with a major hospital group to distribute its hyaluronic acid viscosupplementation products across multiple U.S. states.
Q2 2025: Anika Therapeutics Appoints New Chief Commercial Officer to Drive Viscosupplementation Growth Anika Therapeutics appointed a new Chief Commercial Officer to lead the expansion of its viscosupplementation business in North America and Europe.
Q1 2025: Zimmer Biomet Receives Health Canada Approval for Gel-One Hyaluronate Zimmer Biomet received regulatory approval from Health Canada for its Gel-One Hyaluronate, allowing the company to market its single-injection viscosupplement in Canada.
Q3 2024: Sanofi Signs Distribution Agreement with MedTech Distributor for Viscosupplementation Portfolio in Latin America Sanofi signed a distribution agreement with a leading MedTech distributor to expand the reach of its viscosupplementation products in key Latin American markets.
Q2 2024: Roche Announces Investment in R&D for Next-Generation Viscosupplementation Therapies F. Hoffmann-La Roche announced a significant investment in research and development focused on next-generation viscosupplementation therapies for osteoarthritis.
Q1 2025: LG Chem Launches New Hyaluronic Acid Viscosupplement in South Korea LG Chem launched a new hyaluronic acid-based viscosupplement for the treatment of knee osteoarthritis in the South Korean market.
Q2 2025: Chugai Pharmaceutical Receives Regulatory Approval for Suvenyl Next in Taiwan Chugai Pharmaceutical received regulatory approval for its Suvenyl Next viscosupplement in Taiwan, expanding its presence in the Asia-Pacific region.

Future Outlook

Viscosupplementation Market Future Outlook

The Global Viscosupplementation Market is projected to grow at a 4.76% CAGR from 2025 to 2035, driven by increasing aging populations, rising prevalence of osteoarthritis, and advancements in product formulations.

New opportunities lie in:

Develop innovative, long-lasting viscosupplements to enhance patient outcomes. Expand distribution channels in emerging markets to capture new customer segments. Invest in R&D for combination therapies integrating viscosupplementation with regenerative medicine.

By 2035, the market is expected to demonstrate robust growth, positioning itself as a key player in orthopedic treatments.

Market Segmentation

Outlook

North America
Europe
South America
Asia Pacific
Middle East and Africa

Viscosupplementation Market End-Use Outlook

Hospitals
Clinics
Ambulatory Surgical Centers
Rehabilitation Centers

Viscosupplementation Market Application Outlook

Osteoarthritis
Rheumatoid Arthritis
Sports Injuries
Joint Surgery
Other Orthopedic Conditions

Viscosupplementation Market Product Type Outlook

Hyaluronic Acid
Protein-Based Products
Steroid Injections
Platelet-Rich Plasma
Other Viscosupplements

Viscosupplementation Market Route of Administration Outlook

Intra-Articular Injection
Intravenous Injection
Intrasynovial Injection

Report Scope

Report Attribute/Metric Source:	Details
MARKET SIZE 2024	2.60 USD Billion)
MARKET SIZE 2035	7.31 (USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.84% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Orthogen AG, Zimmer Biomet, Galderma, Medytox, Fidia Farmaceutici, MediCane Health, Baxter International, Stryker Corporation, Boehringer Ingelheim, Revance Therapeutics, Hyaluronic Acid, Allergan, Bausch Health Companies, JointMed, Sanofi
SEGMENTS COVERED	Application, Product Type, Route of Administration, End Use, Regional
KEY MARKET OPPORTUNITIES	Aging population demand, Increased prevalence of osteoarthritis, Rising awareness of minimally invasive treatments, Expanding geriatric healthcare infrastructure, Growth in sports medicine applications
KEY MARKET DYNAMICS	Rising osteoarthritis prevalence, Growing aging population, Increasing preference for minimally invasive treatments, Advances in hyaluronic acid formulations, Expanding applications in joint therapies
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA
Base Year	2024
Market Forecast Period	2025 - 2035